Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048497044> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W3048497044 endingPage "C109" @default.
- W3048497044 startingPage "C109" @default.
- W3048497044 abstract "Abstract Epigenetic drugs, such as histone deacetylase inhibitors (HDACi), are continuing to emerge as promising therapies for various cancers. These drugs, including FDA-approved vorinostat, are capable of multiple actions and considered to be multifunctional. Histone deacetylases (HDAC) are chromatin-modifying enzymes that are involved in various cellular events, such as tissue differentiation, autophagy, apoptosis, migration, mitosis and angiogenesis. High levels of HDACs have been detected in several cancers. Early studies in our laboratory showed different effects by vorinostat on global HDAC activity in several triple-negative breast cancer (TNBC) subtypes. This study focused on HDAC 7, which has been associated with increases in cancer stem cells and poor prognosis. Cancer stem cells play an important role in cancer resistance to therapy. Histone deacetylase inhibitors are emerging as therapy for triple-negative breast cancer, which is currently an unmet need in women's health due to the lack of targeted therapies. This study investigated the effects of vorinostat on apoptosis and the modulation of HDAC 7 expression in two subtypes of triple-negative breast cancers, MB231(MSL) and HCC70 (BL-2). Using caspase 3/7 assays vorinostat induced apoptosis. Additionally, flow cytometry and immunostaining were conducted to determine vorinostat's effects on expression of two cancer stem cell (CSC) markers, CD44 and CD24. Western blot and real-time PCR showed a significant decrease (10-fold) in the expression of HDAC 7 by vorinostat in HCC70 cells. A modest decrease (3-fold) was also observed in MB231 cells. CD44 expression was deceased by vorinostat in MB231 cells. This study demonstrated that vorinostat exerts its anticancer effects through several mechanisms, such as inducing apoptosis, downregulating HDAC 7 and decreasing cancer stem cells. This therapy could be beneficial for subtypes of TNBC, such as HCC70, an aggressive basal-like 2 cell line from an African American. Citation Format: Fatemeh Nouri Emamzadeh, Anfernee Hawkins, Gustavo Miranda-Carboni, Rhonda Moore, Beverly Word, Beverly Lyn-Cook. Modulation of HDAC activity in subtypes of triple-negative breast cancer: Effects of vorinostat on HDAC 7 expression and cancer stem cells progression [abstract]. In: Proceedings of the Eleventh AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2018 Nov 2-5; New Orleans, LA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(6 Suppl):Abstract nr C109." @default.
- W3048497044 created "2020-08-18" @default.
- W3048497044 creator A5027210775 @default.
- W3048497044 creator A5033077608 @default.
- W3048497044 creator A5050491133 @default.
- W3048497044 creator A5052434906 @default.
- W3048497044 creator A5057446885 @default.
- W3048497044 creator A5064931488 @default.
- W3048497044 date "2020-06-01" @default.
- W3048497044 modified "2023-10-02" @default.
- W3048497044 title "Abstract C109: Modulation of HDAC activity in subtypes of triple-negative breast cancer: Effects of vorinostat on HDAC 7 expression and cancer stem cells progression" @default.
- W3048497044 doi "https://doi.org/10.1158/1538-7755.disp18-c109" @default.
- W3048497044 hasPublicationYear "2020" @default.
- W3048497044 type Work @default.
- W3048497044 sameAs 3048497044 @default.
- W3048497044 citedByCount "0" @default.
- W3048497044 crossrefType "journal-article" @default.
- W3048497044 hasAuthorship W3048497044A5027210775 @default.
- W3048497044 hasAuthorship W3048497044A5033077608 @default.
- W3048497044 hasAuthorship W3048497044A5050491133 @default.
- W3048497044 hasAuthorship W3048497044A5052434906 @default.
- W3048497044 hasAuthorship W3048497044A5057446885 @default.
- W3048497044 hasAuthorship W3048497044A5064931488 @default.
- W3048497044 hasConcept C104317684 @default.
- W3048497044 hasConcept C121608353 @default.
- W3048497044 hasConcept C126322002 @default.
- W3048497044 hasConcept C1491633281 @default.
- W3048497044 hasConcept C2776202225 @default.
- W3048497044 hasConcept C2776262904 @default.
- W3048497044 hasConcept C2778305200 @default.
- W3048497044 hasConcept C2780110267 @default.
- W3048497044 hasConcept C2780932548 @default.
- W3048497044 hasConcept C28328180 @default.
- W3048497044 hasConcept C502942594 @default.
- W3048497044 hasConcept C530470458 @default.
- W3048497044 hasConcept C54355233 @default.
- W3048497044 hasConcept C55427017 @default.
- W3048497044 hasConcept C64927066 @default.
- W3048497044 hasConcept C71924100 @default.
- W3048497044 hasConcept C86803240 @default.
- W3048497044 hasConcept C95444343 @default.
- W3048497044 hasConceptScore W3048497044C104317684 @default.
- W3048497044 hasConceptScore W3048497044C121608353 @default.
- W3048497044 hasConceptScore W3048497044C126322002 @default.
- W3048497044 hasConceptScore W3048497044C1491633281 @default.
- W3048497044 hasConceptScore W3048497044C2776202225 @default.
- W3048497044 hasConceptScore W3048497044C2776262904 @default.
- W3048497044 hasConceptScore W3048497044C2778305200 @default.
- W3048497044 hasConceptScore W3048497044C2780110267 @default.
- W3048497044 hasConceptScore W3048497044C2780932548 @default.
- W3048497044 hasConceptScore W3048497044C28328180 @default.
- W3048497044 hasConceptScore W3048497044C502942594 @default.
- W3048497044 hasConceptScore W3048497044C530470458 @default.
- W3048497044 hasConceptScore W3048497044C54355233 @default.
- W3048497044 hasConceptScore W3048497044C55427017 @default.
- W3048497044 hasConceptScore W3048497044C64927066 @default.
- W3048497044 hasConceptScore W3048497044C71924100 @default.
- W3048497044 hasConceptScore W3048497044C86803240 @default.
- W3048497044 hasConceptScore W3048497044C95444343 @default.
- W3048497044 hasIssue "6_Supplement_1" @default.
- W3048497044 hasLocation W30484970441 @default.
- W3048497044 hasOpenAccess W3048497044 @default.
- W3048497044 hasPrimaryLocation W30484970441 @default.
- W3048497044 hasRelatedWork W2004082434 @default.
- W3048497044 hasRelatedWork W2049555579 @default.
- W3048497044 hasRelatedWork W2247891169 @default.
- W3048497044 hasRelatedWork W2740863466 @default.
- W3048497044 hasRelatedWork W2883892389 @default.
- W3048497044 hasRelatedWork W2884256627 @default.
- W3048497044 hasRelatedWork W2955516014 @default.
- W3048497044 hasRelatedWork W4361257795 @default.
- W3048497044 hasRelatedWork W4361804906 @default.
- W3048497044 hasRelatedWork W4367675057 @default.
- W3048497044 hasVolume "29" @default.
- W3048497044 isParatext "false" @default.
- W3048497044 isRetracted "false" @default.
- W3048497044 magId "3048497044" @default.
- W3048497044 workType "article" @default.